Status:
COMPLETED
COVID-19 Survival - The COVIVA Study
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
COVID-19
SARS-CoV 2
Eligibility:
All Genders
18+ years
Brief Summary
The COVID-19 pandemic poses a major and imminent challenge for health care systems regarding patient triage and allocation of limited resources worldwide. The involved pathogenetic mechanisms as well ...
Detailed Description
Background: The current COVID-19 pandemic poses a major and imminent challenge for health care systems regarding patient triage and allocation of limited resources worldwide, but also in Switzerland. ...
Eligibility Criteria
Inclusion
- Clinically suspected or confirmed SARS-CoV-2 infection triaged to the ED
- SARS-CoV-2 swab test performed (result may be pending at time of study enrolment)
- Age ≥18 years
- Patient or legally authorized representative is willing to sign local General consent form
Exclusion
- Patient or legally authorized representative is unable or unwilling to participate in the study.
Key Trial Info
Start Date :
March 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
1325 Patients enrolled
Trial Details
Trial ID
NCT04366765
Start Date
March 19 2020
End Date
June 30 2021
Last Update
October 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel
Basel, Switzerland, 4031